Pharmacy Practice and Science

Research output

Research output per year 1970 2009 2010 2016 2017 2018 2019 2020 2021 2022 2023 2024 2024

• 52724 Citations
• 100 h-index
• 1606 Article
• 316 Review article
• 173 Comment/debate
• 149 Letter
• 145 More
  • 43 Editorial
  • 25 Conference contribution
  • 22 Short survey
  • 21 Chapter
  • 17 Meeting Abstract
  • 8 Other contribution
  • 7 Preprint
  • 1 Foreword/postscript
  • 1 Scientific review

Research output per year

Research output per year

Search results

• 2017

  Dementia for the Primary Care Provider

  Moga, D. C., Roberts, M. & Jicha, G., Sep 2017, In: Primary Care - Clinics in Office Practice. 44, 3, p. 439-456 18 p.

  Research output: Contribution to journal › Review article › peer-review

  • Dementia 100%
  • Primary Health Care 100%
  • Primary Medical Care 100%
  • Therapeutic Procedure 60%
  • Diagnosis 20%
  8 Scopus citations

• Dinutuximab for maintenance therapy in pediatric neuroblastoma

  McGinty, L. & Kolesar, J., Apr 15 2017, In: American Journal of Health-System Pharmacy. 74, 8, p. 563-567 5 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Pediatrics 100%
  • Ganglioneuroblastoma 100%
  • Maintenance Therapy 100%
  • Dinutuximab 100%
  • Neuroblastoma 100%
  24 Scopus citations

• Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations

  Bain, J., Flannery, A. H., Flynn, J. & Dager, W., Jul 1 2017, In: Journal of Thrombosis and Thrombolysis. 44, 1, p. 76-87 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Heparin Induced Thrombocytopenia 100%
  • Devices 100%
  • Assisted Circulation 100%
  • Heparin-Induced Thrombocytopenia 100%
  • Patient 66%
  14 Scopus citations

• Potentially clinically relevant pharmacodynamic interactions between antiepileptic drugs and psychotropic drugs: An update

  Spina, E. & de Leon, J., Oct 1 2017, In: Current Pharmaceutical Design. 23, 37, p. 5625-5638 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacodynamics 100%
  • Anticonvulsive Agent 100%
  • Psychotropic Agent 100%
  • Drug Interaction 100%
  • Antidepressant 20%
  15 Scopus citations

• Retention throughout the HIV care and treatment cascade: From diagnosis to antiretroviral treatment of adults and children living with HIV - Haiti, 1985-2015

  Oct 2017, In: American Journal of Tropical Medicine and Hygiene. 97, p. 57-70 14 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Diagnosis 100%
  • Therapeutic Procedure 100%
  • Adult 100%
  • Child 100%
  • Human Immunodeficiency Virus 100%
  11 Scopus citations

• Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

  Wagner, L. M. & Adams, V. R., Apr 12 2017, In: OncoTargets and Therapy. 10, p. 2097-2106 10 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Pediatrics 100%
  • Programmed Cell Death 100%
  • Solid Malignant Neoplasm 100%
  • Intracranial Tumor 100%
  • Therapeutic Procedure 66%
  45 Scopus citations

• The art of pharmacotherapy: Reflections on pharmacophobia

  De Leon, J. & De Las Cuevas, C., Apr 1 2017, In: Journal of Clinical Psychopharmacology. 37, 2, p. 131-137 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacotherapy 100%
  • Psychopharmacology 100%
  • Health Belief 60%
  • Psychopharmacotherapy 20%
  • Drug 20%
  23 Scopus citations
• 2016

  Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy

  Smetana, K. S., Cook, A. M., Bastin, M. L. T. & Oyler, D. R., Dec 1 2016, In: Journal of Critical Care. 36, p. 116-124 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Replacement Therapy 100%
  • Anticonvulsive Agent 40%
  • Toxicology 20%
  • Case Report 20%
  • Pharmacokinetic Parameter 20%
  30 Scopus citations

• Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics

  Spina, E., Hiemke, C. & De Leon, J., Apr 2 2016, In: Expert Opinion on Drug Metabolism and Toxicology. 12, 4, p. 407-422 16 p.

  Research output: Contribution to journal › Review article › peer-review

  • Drug-Drug Interaction 100%
  • Therapeutic Drug Monitoring 100%
  • Typical Antipsychotic 100%
  • Pharmacokinetics 37%
  • Case Report 25%
  90 Scopus citations

• Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic review

  Bergsbaken, J. J., Eickhoff, J. C., Buss, B. A., Mably, M. S. & Kolesar, J. M., Feb 2016, In: Journal of Oncology Pharmacy Practice. 22, 1, p. 105-113 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Clinical Trial 100%
  • Anticarcinogen 100%
  • Malignant Neoplasm 40%
  • Controlled Clinical Trial 20%
  • Breast Cancer 20%
  8 Scopus citations

• Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics

  Spina, E., Pisani, F. & De Leon, J., Apr 1 2016, In: Pharmacological Research. 106, p. 72-86 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Antidepressant 100%
  • Anticonvulsive Agent 100%
  • Drug Interaction 100%
  • Typical Antipsychotic 100%
  • Pharmacokinetics 100%
  91 Scopus citations

• Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?

  Elgendy, I. Y., Mahmoud, A. N., Mansoor, H., Mojadidi, M. K. & Bavry, A. A., Nov 1 2016, In: International Journal of Cardiology. 222, p. 441-447 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Evolution 100%
  • Brain Ischemia 100%
  • Thrombectomy 100%
  • Acute Heart Infarction 100%
  • Stroke Therapy 100%
  17 Scopus citations

• Identifying best practices for and utilities of the pharmacy curriculum outcome assessment examination

  Mok, T. Y. & Romanelli, F., 2016, In: American Journal of Pharmaceutical Education. 80, 10, 163.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacology 100%
  16 Scopus citations

• Olaparib for the treatment of BRCA-mutated advanced ovarian cancer

  Munroe, M. & Kolesar, J., Jul 15 2016, In: American Journal of Health-System Pharmacy. 73, 14, p. 1037-1041 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Therapeutic Procedure 100%
  • Ovarian Cancer 100%
  • Olaparib 100%
  • Ovary Cancer 100%
  • Patient 41%
  26 Scopus citations

• Patterns of Comorbidity of Suicide Attempters: An Update

  Blasco-Fontecilla, H., Rodrigo-Yanguas, M., Giner, L., Lobato-Rodriguez, M. J. & de Leon, J., Oct 1 2016, In: Current Psychiatry Reports. 18, 10, 93.

  Research output: Contribution to journal › Review article › peer-review

  • Axis 100%
  • Comorbidity 100%
  • Review 25%
  • Prognosis 25%
  • Cause 25%
  14 Scopus citations

• PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

  Medina, P. J. & Adams, V. R., Mar 1 2016, In: Pharmacotherapy. 36, 3, p. 317-334 18 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Immune Response 100%
  • Patient 100%
  • Oncology 100%
  • Immunoglobulin 100%
  • Nivolumab 100%
  75 Scopus citations

• Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma

  Ivashko, I. N. & Kolesar, J. M., Feb 15 2016, In: American Journal of Health-System Pharmacy. 73, 4, p. 193-201 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Melanoma 100%
  • Nivolumab 100%
  • Pembrolizumab 100%
  • Therapeutic Procedure 62%
  • Toxicity 37%
  71 Scopus citations

• Pharmacogenetic tests in psychiatry

  De Leon, J., Aug 1 2016, In: Journal of Clinical Psychopharmacology. 36, 4, p. 299-304 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacogenetics 100%
  29 Scopus citations

• Practical insights for the pharmacist educator on student engagement

  Oyler, D. R., Romanelli, F., Piascik, P. & Cain, J., 2016, In: American Journal of Pharmaceutical Education. 80, 8, 143.

  Research output: Contribution to journal › Review article › peer-review

  • Students 100%
  • Pharmacist 100%
  • Student 100%
  • Pharmacology 100%
  • Education 20%
  17 Scopus citations

• Research, perspectives, and recommendations on implementing the flipped classroom

  Rotellar, C. & Cain, J., 2016, In: American Journal of Pharmaceutical Education. 80, 2, 34.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Research 100%
  • Perspective 100%
  • Students 100%
  • Flipped Classroom 100%
  • Academic Teaching Personnel 66%
  165 Scopus citations

• Treatment of chronic myelogenous leukemia

  Kujak, C. & Kolesar, J. M., Feb 1 2016, In: American Journal of Health-System Pharmacy. 73, 3, p. 113-120 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Dasatinib 100%
  • Nilotinib 100%
  • Chronic Myeloid Leukemia 100%
  • Protein Tyrosine Kinase Inhibitor 50%
  • Imatinib 50%
  15 Scopus citations

• Unpeeling the evidence for the banana bag: Evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU

  Flannery, A. H., Adkins, D. A. & Cook, A. M., Aug 1 2016, In: Critical Care Medicine. 44, 8, p. 1545-1552 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Patient 100%
  • Alcohol 100%
  • Vitamin 100%
  • Electrolyte 100%
  • Ethanol 100%
  49 Scopus citations

• What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?

  De Leon, J. & Spina, E., Mar 3 2016, In: Expert Review of Clinical Pharmacology. 9, 3, p. 351-354 4 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Food and Drug Administration 100%
  • Psychopharmacotherapy 100%
  • Pharmacogenetics 100%
  • Patient 50%
  • Drug 50%
  15 Scopus citations
• 2015

  A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults

  Jackson, J. G., Diaz, F. J., Lopez, L. & de Leon, J., Sep 1 2015, In: Bipolar Disorders. 17, 6, p. 575-597 23 p.

  Research output: Contribution to journal › Review article › peer-review

  • Smoking 100%
  • Bipolar Disorder 100%
  • Behavior 100%
  • Behavior (Neuroscience) 100%
  • Schizophrenia 45%
  85 Scopus citations

• Clinical applications of CYP genotyping in psychiatry

  Spina, E. & de Leon, J., Jan 17 2015, In: Journal of Neural Transmission. 122, 1, p. 5-28 24 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Cytochrome P450 2D6 100%
  • Psychiatry 100%
  • Cytochrome P450 100%
  • Genotype 100%
  • CYP2D6 100%
  126 Scopus citations

• Clozapine for treatment-resistant bipolar disorder: A systematic review

  Li, X. B., Tang, Y. L., Wang, C. Y. & de Leon, J., May 1 2015, In: Bipolar Disorders. 17, 3, p. 235-247 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Clozapine 100%
  • Bipolar Disorder 100%
  • Adverse Drug Reaction 42%
  • Symptom 42%
  • Monotherapy 28%
  114 Scopus citations

• From the Serotonin Model of Suicide to a Mental Pain Model of Suicide

  De Leon, J., Baca-Garciá, E. & Blasco-Fontecilla, H., Oct 14 2015, In: Psychotherapy and Psychosomatics. 84, 6, p. 323-329 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Serotonin 100%
  38 Scopus citations

• Is psychiatry only neurology? or only abnormal psychology? Déjà vu after 100 years

  De Leon, J., Nov 13 2015, In: Acta Neuropsychiatrica. 27, 2, p. 69-81 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Psychiatry 100%
  • Neurology 100%
  • Disease 100%
  • Group 100%
  • Psychology 100%
  18 Scopus citations

• Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer

  Rounds, A. & Kolesar, J., Nov 1 2015, In: American Journal of Health-System Pharmacy. 72, 21, p. 1851-1855 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Therapeutic Procedure 100%
  • Non Small Cell Lung Cancer 100%
  • Nivolumab 100%
  • Patient 55%
  • Squamous Cell 33%
  18 Scopus citations

• Nonopioid management of acute pain associated with trauma: Focus on pharmacologic options

  Oyler, D. R., Parli, S. E., Bernard, A. C., Chang, P. K., Procter, L. D. & Harned, M. E., Sep 5 2015, In: Journal of Trauma and Acute Care Surgery. 79, 3, p. 475-483 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Opiate 100%
  • Injury 100%
  • Pain 100%
  • Analgesia 100%
  • Therapeutic Procedure 100%
  24 Scopus citations

• Note-taking and handouts in the digital age

  Stacy, E. M. & Cain, J., 2015, In: American Journal of Pharmaceutical Education. 79, 7, 107.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Informal Learning 100%
  • Mobile Technology 100%
  • Critical Component 100%
  • Future Direction 100%
  • Tablet Computer 100%
  49 Scopus citations
• 2014

  Afatinib: A first-line treatment for selected patients with metastatic non-small-cell lung cancer

  Engle, J. A. & Kolesar, J. M., Nov 15 2014, In: American Journal of Health-System Pharmacy. 71, 22, p. 1933-1938 6 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Non Small Cell Lung Cancer 100%
  • Afatinib 100%
  • Epidermal Growth Factor Receptor 66%
  • Chemotherapy 22%
  • Adverse Event 22%
  17 Scopus citations

• Clinically relevant interactions between newer antidepressants and second-generation antipsychotics

  Spina, E. & De Leon, J., May 2014, In: Expert Opinion on Drug Metabolism and Toxicology. 10, 5, p. 721-746 26 p.

  Research output: Contribution to journal › Review article › peer-review

  • Antidepressant 100%
  • Typical Antipsychotic 100%
  • Risperidone 66%
  • Aripiprazole 66%
  • Iloperidone 66%
  100 Scopus citations

• False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology: Part II: Focus on bipolar disorder

  De Leon, J., Jun 2014, In: Journal of Clinical Psychopharmacology. 34, 3, p. 291-296 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Bipolar Disorder 100%
  • Psychopharmacology 100%
  20 Scopus citations

• False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology. Part I: Focus on epilepsy

  De Leon, J., Apr 2014, In: Journal of Clinical Psychopharmacology. 34, 2, p. 177-183 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Epilepsy 100%
  • Psychopharmacology 100%
  11 Scopus citations

• Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry

  De Leon, J., Jun 19 2014, In: Acta Neuropsychiatrica. 26, 6, p. 327-333 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Diseases 100%
  • Drug 100%
  • Personalized Medicine 100%
  • Psychiatry 100%
  • Disease 100%
  13 Scopus citations

• Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function

  Fermiano, M., Bergsbaken, J. & Kolesar, J. M., May 15 2014, In: American Journal of Health-System Pharmacy. 71, 10, p. 793-798 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Methotrexate 100%
  • Carboxypeptidase G2 100%
  • Clinical Trial 22%
  • Toxicity 22%
  • Adverse Event 22%
  15 Scopus citations

• One hundred years of limited impact of jaspers' general psychopathology on us psychiatry

  De Leon, J., Feb 2014, In: Journal of Nervous and Mental Disease. 202, 2, p. 79-87 9 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Hybrid 100%
  • Comprehension 50%
  • DSM-III 50%
  14 Scopus citations

• Oseltamivir Dosing in Critically Ill Patients With Severe Influenza

  Flannery, A. H. & Thompson Bastin, M. L., Aug 2014, In: Annals of Pharmacotherapy. 48, 8, p. 1011-1018 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Influenza 100%
  • Oseltamivir 100%
  • Human 50%
  • Pharmacokinetics 50%
  • Replacement Therapy 33%
  20 Scopus citations

• Paradoxes of US psychopharmacology practice in 2013: Undertreatment of severe mental illness and overtreatment of minor psychiatric problems

  De Leon, J., Oct 2014, In: Journal of Clinical Psychopharmacology. 34, 5, p. 545-548 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Mental Illness 100%
  • Psychopharmacology 100%
  • Severe Mental Illness 100%
  8 Scopus citations

• Pathophysiology and pharmacologic treatment of venous thromboembolism

  Bain, J., Oyler, D. R., Smyth, S. S. & Macaulay, T. E., 2014, In: Current Drug Targets. 15, 2, p. 199-209 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Therapeutic Procedure 100%
  • Pathophysiology 100%
  • Venous Thromboembolism 100%
  • Vein Thrombosis 100%
  • Phlebothrombosis 83%
  3 Scopus citations

• Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants

  Italiano, D., Spina, E. & De Leon, J., Nov 1 2014, In: Expert Opinion on Drug Metabolism and Toxicology. 10, 11, p. 1457-1489 33 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Pharmacodynamics 100%
  • Antidepressant 100%
  • Pharmacokinetics 100%
  • Drug Interaction 83%
  • Sodium Valproate 33%
  47 Scopus citations

• The fact of ignorance revisiting the socratic method as a tool for teaching critical thinking

  Oyler, D. R. & Romanelli, F., 2014, In: American Journal of Pharmaceutical Education. 78, 7, 144.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Teaching 100%
  • Critical Thinking 100%
  • Procedure 100%
  • Tools 100%
  • Procedures 100%
  42 Scopus citations

• Transforming the curriculum vitae as a new practitioner

  Flannery, A. H., Winstead, P. S. & Smith, K. M., Dec 15 2014, In: American Journal of Health-System Pharmacy. 71, 24, p. 2115-2117 3 p.

  Research output: Contribution to journal › Review article › peer-review

  • curriculum vitae 100%
  2 Scopus citations
• 2013

  Clobazam therapeutic drug monitoring: A comprehensive review of the literature with proposals to improve future studies

  De Leon, J., Spina, E. & Diaz, F. J., Feb 2013, In: Therapeutic Drug Monitoring. 35, 1, p. 30-47 18 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Clobazam 100%
  • Therapeutic Drug Monitoring 100%
  • Norclobazam 46%
  • Dose Concentration 40%
  • CYP2C19 26%
  74 Scopus citations

• Crizotinib for the treatment of non-small-cell lung cancer

  Timm, A. & Kolesar, J. M., Jun 1 2013, In: American Journal of Health-System Pharmacy. 70, 11, p. 943-947 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Non Small Cell Lung Cancer 100%
  • Crizotinib 100%
  • Anaplastic Lymphoma Kinase 33%
  • Adverse Event 16%
  • Clinical Trial 8%
  24 Scopus citations

• New treatment options for castration-resistant prostate cancer.

  Simondsen, K. & Kolesar, J., May 15 2013, In: Unknown Journal. 70, 10, p. 856-865 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Castration Resistant Prostate Cancer 100%
  • Cabazitaxel 60%
  • Overall Survival 60%
  • Abiraterone Acetate 60%
  • Sipuleucel T 60%
  7 Scopus citations

• The reversal of inhibitors in congenital hemophilia

  Defrates, S. R., McDonagh, K. T. & Adams, V. R., Feb 2013, In: Pharmacotherapy. 33, 2, p. 157-164 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Blood Clotting Factor 9 100%
  • Blood Clotting Factor 8 100%
  • Haemophilia A 100%
  • Therapeutic Procedure 100%
  • Patient 50%
  10 Scopus citations

• Vandetanib: a novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer.

  Ton, G. T. N., Banaszynski, M. E. & Kolesar, J. M., May 15 2013, In: Unknown Journal. 70, 10, p. 849-855 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Vandetanib 100%
  • Thyroid Cancer 100%
  • Placebo 33%
  • Cardiotoxicity 8%
  • Drug Tolerability 8%
  22 Scopus citations

• Vemurafenib and ipilimumab: New agents for metastatic melanoma

  Banaszynski, M. & Kolesar, J. M., Jul 15 2013, In: American Journal of Health-System Pharmacy. 70, 14, p. 1205-1210 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Metastatic Melanoma 100%
  • Vemurafenib 100%
  • Ipilimumab 100%
  • Clinical Trial 22%
  • Antitumor Activity 22%
  19 Scopus citations